Use of concurrent sedating agents provides rapid sedation and reduces the need for resedation in acutely agitated patients, according to clinical trial results published online September 14 in the Annals of Emergency Medicine.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.